Alejandro González Veliz: Does Elevated Lp(a) Always Mean the Same Cardiovascular Risk?
Alejandro González Veliz, Interventional Cardiologist at Institute of Cardiology and Cardiovascular Surgery, shared a post on LinkedIn about recent article by Niekbachsh Mohammadnia et al., published in JAMA Cardiology, adding:
“Does elevated Lp(a) always mean the same cardiovascular risk?
This new JAMA Cardiology study suggests the answer is no.
Among more than 43,000 individuals followed for over 13 years, IL-6 emerged as the only inflammatory biomarker that significantly modified the association between elevated Lp(a) and incident coronary artery disease.
Patients with both high Lp(a) and high IL-6 had substantially greater coronary risk, whereas elevated Lp(a) alone carried much less excess risk when IL-6 levels were low.
Interestingly, this interaction was not observed for aortic stenosis, suggesting different biological mechanisms despite Lp(a) being a shared risk factor.
These findings reinforce the concept that cardiovascular prevention may increasingly rely on combining lipid biology with inflammatory profiling, potentially helping identify those who could derive the greatest benefit from emerging Lp(a)-lowering and anti-inflammatory therapies.
What do you think will become the next essential biomarker in preventive cardiology: IL-6, hsCRP, or something else?”
Title: Lipoprotein(a), Inflammation, and Risk of Coronary Artery Disease and Aortic Valve Stenosis
Authors: Niekbachsh Mohammadnia, Linke Li, Daniel Ezzat, Zhi Yu, Vineet K. Raghu, Jennifer L. Halford, Niels P. Riksen, Pradeep Natarajan, Jan H. Cornel, Michael C. Honigberg, Saloua El Messaoudi

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 4, 2026, 15:06Vasiliki Gkalea: Journal of Clinical Medicine Launches Special Issue on Hematologic Thrombosis and Bleeding
-
Oct 4, 2026, 14:55Quentin Brebant: What Defines a High-Quality Red Blood Cell Concentrate?
-
Oct 4, 2026, 14:47Rana Al-Hrout: Recognizing Non-Anemic Iron Deficiency – Why Iron Matters Beyond Hemoglobin
-
Oct 4, 2026, 14:41David McIntosh: International Plasma Awareness Week 2026 – Closing the Global Plasma Gap
-
Oct 4, 2026, 14:33Pete Stibbs: CleanerVac Real-World Study Presented at VIVA and The VEINS 2026
-
Oct 4, 2026, 13:56Maria Elisa Mancuso: EHC 2026 Highlights the Unmet Needs of Women with Bleeding Disorders
-
Oct 4, 2026, 13:53Nirmal Shaji George: Individualizing Anticoagulation in Complex APS and Thrombocytopenia
-
Oct 4, 2026, 13:5210 Posts Not to Miss This Week
-
Oct 4, 2026, 13:45Suswapna Singh Rawat: The Clinical Significance of Coronary Plaque Stability